Recent news on Gastrin

Transition Therapeutics Announces Third Quarter Fiscal 2007 ...  -  May 16, 2007
PharmaLive.com (press release),These clinical data support the potential of gastrin as a therapeutic in combination with other diabetes therapies. Transition holds the exclusive rights to

Regulation of GH secretagogue receptor (GHS-R) gene expression in ...  -  May 10, 2007
Journal of EndocrinologyCholecystokinin and gastrin increased the level of GHS-R mRNA after 2 h, but after 4 h the level decreased. These results suggest that GHS-R synthesis in

Selection of Radiolabeled Gastrin Analogs for Peptide Receptor ...  -  Mar 30, 2007
Journal of Nuclear Medicine (subscription)The gastrin/cholecystokinin-2 (CCK-2) receptor has been identified as a possible target for peptide receptor radionuclide imaging and therapy.

High Gastrin Cell Activity and Low Ghrelin Cell Activity in High ...  -  Mar 13, 2007
Journal of EndocrinologyThe two strains were also compared with respect to plasma gastrin, a gastric hormone with a pre- and postprandial release pattern opposite to that of

Transition Therapeutics Announces Positive Data from E1-INT(TM ...  -  Mar 22, 2007
Drug Newswire (press release),..."With its novel mode of action, E1-INT(TM) leads a new class of gastrin-based therapeutics for development in the treatment of diabetes.

Clinical Trial of Diabetes Regenerative Therapy Shows Positive Results  -  Mar 8, 2007
Juvenile Diabetes Research FoundationWith a JDRF grant, scientists identified that the hormone gastrin had beta cell regenerative therapeutic potential. Continued testing through the 1990s of

Evaluation of Possible Gastrinoma  -  Feb 14, 2007
Medscape (subscription)Because of the history of peptic ulcer disease and diarrhea, the diagnosis of Zollinger-Ellison syndrome (ZES; gastrin-secreting tumor) was considered.

Biohit Oyj: Financial statement report of biohit group 1 jan to 31 ...  -  Feb 16, 2007
Kauppalehti (press release),All GastroPanel tests (Pepsinogen I and II, Gastrin-17 and Helicobacter pylori IgA and IgG antibodies) have currently been granted marketing authorisations

Biotech IPO Watch: Molecular Insight Seeks Imaging and ...  -  Feb 4, 2007
Seeking Alpha,Onalta is an yttrium-90 radiolabeled somatostatin peptide analog that inhibits the secretion of growth hormones, insulin and gastrin.

Androgen-Dependent Expression of the Gastrin-Releasing Peptide ...  -  Jan 4, 2007
Journal of Nuclear Medicine (subscription)Human prostate cancers (PC) overexpress gastrin-releasing peptide (GRP) receptors. This observation suggests that GRP receptors may be used as new

Biohit Oyj: Biohit’s innovative gastropanel to be used in china’s ...  -  Jan 5, 2007
Kauppalehti (press release),In its recommendation, the working group approved the tests (Gastrin-17, Pepsinogen I and Pepsinogen II as well as Helicobacter pylori antibodies) for use

Serum Tests Key to Gastric Cancer Detection  -  Jan 8, 2007
Kansas City infoZine,After evaluating the risk of atrophic gastritis and gastric cancer with serological tests, researchers have concluded that serum pepsinogen, gastrin-17 and

Zollinger-Ellison syndrome: Esomeprazole maintains normal acid ...  -  Dec 17, 2006
Xagena.it,Zollinger-Ellison syndrome, a serious chronic condition, is characterized by the development of a tumor or tumors that secrete excessive levels of gastrin,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional